Germany - Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use
Since 2014, Germany Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use decreased by 0.6% year on year. In 2019, the country was ranked number 8 comparing other countries in Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use at 88.1 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Germany is overtaken by Luxembourg, which was number 7 at 89.4 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Sweden with 82.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Netherlands topped the ranking with 131.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, a growth of 3.9% compared to 2018. Spain, United Kingdom and Iceland respectively ranked number 2, 3 and 4 in this ranking. Canada witnessed the best average annual growth at +11.3% per year, while Austria recorded the worst performance at -14% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 88.10 |
| 2018 | 82.90 |
| 2017 | 88.50 |
| 2016 | 94.70 |
| 2015 | 93.50 |
How does Germany rank in Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Netherlands
|
132 | 2019 | +3.9 % | +3.5 % | View data | |
| 2 |
#2
Spain
|
129 | 2019 | +2.8 % | +0.6 % | View data | |
| 7 |
#7
Luxembourg
|
89 | 2019 | +0.5 % | +0.9 % | View data | |
| 8 |
#8
Germany
|
88 | 2019 | +6.3 % | -0.6 % | View data | |
| 9 |
#9
Sweden
|
83 | 2019 | +3.3 % | +2.5 % | View data | |